SG Americas Securities’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,122
| Closed | -$115K | – | 3089 |
|
|
2025
Q1 | $115K | Buy |
+7,122
| New | +$115K | ﹤0.01% | 2615 |
|
|
2024
Q4 | – | Sell |
-12,589
| Closed | -$370K | – | 3120 |
|
|
2024
Q3 | $370K | Buy |
12,589
+7,044
| +127% | +$207K | ﹤0.01% | 1738 |
|
|
2024
Q2 | $130K | Buy |
+5,545
| New | +$130K | ﹤0.01% | 2109 |
|
|
2022
Q3 | – | Sell |
-713
| Closed | -$9K | – | 3119 |
|
|
2022
Q2 | $9K | Buy |
+713
| New | +$9K | ﹤0.01% | 3022 |
|
|
2022
Q1 | – | Sell |
-441
| Closed | -$52K | – | 2954 |
|
|
2021
Q4 | $52K | Sell |
441
-702
| -61% | -$82.8K | ﹤0.01% | 2862 |
|
|
2021
Q3 | $227K | Buy |
+1,143
| New | +$227K | ﹤0.01% | 2888 |
|
|
2020
Q3 | – | Sell |
-916
| Closed | -$212K | – | 2857 |
|
|
2020
Q2 | $212K | Buy |
916
+499
| +120% | +$115K | ﹤0.01% | 2427 |
|
|
2020
Q1 | $49K | Buy |
+417
| New | +$49K | ﹤0.01% | 2692 |
|